Trial Profile
Comparison of controlled-release nifedipine + standard-dose candesartan versus up-titrated candesartan in patients with hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil/nifedipine (Primary) ; Candesartan cilexetil; Nifedipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms NICE-Combi
- 29 Sep 2016 Results of subanalysis (the relationship between the change of urinary albumin excretion and the changes of serum uric acid) presented at the 26th Scientific Meeting of the International Society of Hypertension
- 05 Nov 2010 New trial record.